Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Perrigo Company PLC    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/11/2019 09/12/2019 09/13/2019 09/16/2019 09/17/2019 Date
55.26(c) 55.96(c) 55.96(c) 56.7(c) 55.72(c) Last
1 843 050 1 651 385 1 340 333 799 105 835 095 Volume
+4.72% +1.27% 0.00% +1.32% -1.73% Change
More quotes
Financials (USD)
Sales 2019 4 791 M
EBIT 2019 802 M
Net income 2019 204 M
Debt 2019 2 758 M
Yield 2019 1,41%
Sales 2020 5 023 M
EBIT 2020 881 M
Net income 2020 417 M
Debt 2020 2 383 M
Yield 2020 1,45%
P/E ratio 2019 43,1x
P/E ratio 2020 21,5x
EV / Sales2019 2,16x
EV / Sales2020 1,98x
Capitalization 7 581 M
More Financials
Company
Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences.... 
Sector
Pharmaceuticals
Calendar
11/07Earnings Release
More about the company
Surperformance© ratings of Perrigo Company PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY PLC
09/17PERRIGO : Charitable Foundation Donates More Than $20,000 to Hurricane Dorian Re..
AQ
09/06PERRIGO : Advances Consumer Self-Care Growth Strategy with Acquisition of Prevac..
AQ
09/05PERRIGO : Buys Prevacid U.S. OTC Rights From GlaxoSmithKline
DJ
08/29PERRIGO COMPANY PLC : Ex-dividend day for
FA
08/16PERRIGO : Sc 13d/a
PU
08/16PERRIGO CO PLC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
08/08PERRIGO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
08/08PERRIGO CO PLC : Results of Operations and Financial Condition, Financial Statem..
AQ
08/08PERRIGO : 2Q Earnings Snapshot
AQ
08/07PERRIGO CO PLC : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Sector news : Pharmaceuticals - NEC
02:32aAstraZeneca Amends China Collaboration Agreement With Ironwood
DJ
09/17ALEXION PHARMACEUTICALS : Names New Finance Chief
DJ
09/17ABBVIE : Form 8.3 - Allergan Plc
DJ
09/17BAYER : Invests $20 Million in U.S.-Based Informed Data Systems
DJ
09/17Merck Gets FDA Priority Review for Investigational Ebola Zaire Virus Vaccine
DJ
More sector news : Pharmaceuticals - NEC
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 52,33  $
Last Close Price 55,72  $
Spread / Highest target 7,68%
Spread / Average Target -6,08%
Spread / Lowest Target -19,2%
EPS Revisions
Managers
NameTitle
Murray S. Kessler President, Chief Executive Officer & Director
Rolf Allan Classon Chairman
Ronald Janish Executive VP-Global Operations and Supply Chain
Ron L. Winowiecki Chief Financial Officer
Thomas Farrington Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY PLC43.79%7 581
JOHNSON & JOHNSON0.38%342 221
ROCHE HOLDING LTD.12.28%240 139
MERCK AND COMPANY7.98%211 257
PFIZER-16.38%201 883
NOVARTIS16.65%198 222